FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.
LNAI holds $491,645 in cash and burns about $133,163/quarter from operations, giving an estimated runway of 11.1 months. A recent offering filing was detected — dilution watch.
Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for LNAI free →
A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for LNAI and 2 more tickers of your choice.
Create Free Account →